These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9364292)

  • 1. Lack of association between vigabatrin and impaired cognition.
    Monaco F; Torta R; Cicolin A; Borio R; Varetto A; Bergamasco L; Vighetti S
    J Int Med Res; 1997; 25(5):296-301. PubMed ID: 9364292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vigabatrin on partial seizures and cognitive function.
    Grünewald RA; Thompson PJ; Corcoran R; Corden Z; Jackson GD; Duncan JS
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1057-63. PubMed ID: 8089668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and cognitive effects of vigabatrin.
    Ylinen A; Kälviäinen R; Riekkinen PJ
    Acta Neurol Scand Suppl; 1995; 162():47-50. PubMed ID: 7495191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group.
    Chadwick D
    Lancet; 1999 Jul; 354(9172):13-9. PubMed ID: 10406359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigabatrin and psychosis: is there a true correlation?
    Veggiotti P; De Agostini G; Baldi PL; Muzio C; Lanzi G
    Acta Neurol Scand; 1997 Mar; 95(3):189-90. PubMed ID: 9088390
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationalized polytherapy for epilepsy.
    Goldsmith P; de Bittencourt PR
    Acta Neurol Scand Suppl; 1995; 162():35-9. PubMed ID: 7495188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients.
    Murri L; Iudice A
    Acta Neurol Scand Suppl; 1995; 162():40-2. PubMed ID: 7495189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsies.
    Gobbi G; Pini A; Bertani G; Menegati E; Tiberti A; Valseriati D; Besana D; Rasmini P; Guerrini R; Belmonte A; Veggiotti P; Resi C; Lanzi G; Capovilla G; Galeone D; Milani S
    Epilepsy Res; 1999 May; 35(1):29-37. PubMed ID: 10232792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children.
    Zamponi N; Cardinali C
    Arch Neurol; 1999 May; 56(5):605-7. PubMed ID: 10328256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
    Gherpelli JL; Guerreiro MM; da Costa JC; Rotta NT; Manreza ML; Reed UC; Diament A; Silva EA; Guerreiro CA; Nunes ML; Palmini A; Vega-Gutiérrez L; Vizioli J; Pedroso F; Chisté MA
    Epilepsy Res; 1997 Dec; 29(1):1-6. PubMed ID: 9416454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin in childhood epilepsy: a 5-year follow-up study.
    Uldall P; Alving J; Gram L; Høgenhaven H
    Neuropediatrics; 1995 Oct; 26(5):253-6. PubMed ID: 8552215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.
    Ruether K; Pung T; Kellner U; Schmitz B; Hartmann C; Seeliger M
    Arch Ophthalmol; 1998 Jun; 116(6):817-9. PubMed ID: 9639460
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversibility of vigabratin-induced visual-field defect.
    Versino M; Veggiotti P
    Lancet; 1999 Aug; 354(9177):486. PubMed ID: 10465180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin and complex partial status.
    Arzimanoglou A
    Seizure; 1994 Mar; 3(1):79-80. PubMed ID: 8044458
    [No Abstract]   [Full Text] [Related]  

  • 16. Vigabatrin use in 72 patients with drug-resistant epilepsy.
    Buchanan N
    Seizure; 1994 Sep; 3(3):191-6. PubMed ID: 8000713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin treatment in children.
    Fois A; Buoni S; Di Bartolo RM; Di Marco V; Mostardini R
    Childs Nerv Syst; 1994 May; 10(4):244-8. PubMed ID: 7923235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin and multifocal myoclonus in adults with partial seizures.
    Neufeld MY; Vishnevska S
    Clin Neuropharmacol; 1995 Jun; 18(3):280-3. PubMed ID: 8635188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin.
    Devinsky O; Vazquez B; Luciano D
    J Child Neurol; 1994 Oct; 9 Suppl 1():S33-45. PubMed ID: 7822751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of neuropsychological deficits in epilepsy using the Luria-Nebraska Neuropsychological Battery: a replication attempt.
    Hermann BP; Melyn M
    J Clin Exp Neuropsychol; 1985 Jun; 7(3):305-13. PubMed ID: 3923033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.